Electroacupuncture for lung cancer patients on immunotherapy
Part of Cancer, Lungs & breathing clinical trials.
This study tests whether adding electroacupuncture at a specific point on the leg (called Zusanli) can help people with lung cancer who are getting chemotherapy and immunotherapy before surgery. It might reduce side effects and improve response to treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with non-small cell lung cancer.
- You are about to receive or are currently receiving chemotherapy plus immunotherapy before surgery.
- You are generally able to care for yourself (ECOG performance status 0 to 2).
- You have at least one tumor that can be measured on a CT scan.
- You do not have certain medical conditions like severe bleeding disorders, uncontrolled diabetes, or a pacemaker.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial explores whether adding electroacupuncture (a gentle needle treatment with mild electric pulses) to standard immunotherapy after lung cancer surgery can help prevent the cancer from coming back. It is designed for people with early-stage non-small cell lung cancer who have already had chemotherapy.
This trial tests whether adding electroacupuncture to a PD-1 inhibitor (a type of immunotherapy) can help people with advanced non-small cell lung cancer who have limited activity levels. It may improve treatment response and quality of life.
This trial tests whether adding electroacupuncture (a gentle, needle-based therapy) to a standard immunotherapy drug (PD-1 inhibitor) can help older adults with advanced lung cancer. It may improve treatment response and quality of life.
This trial tests whether combining electroacupuncture with self-acupressure can improve quality of life for people with early-stage breast cancer during chemotherapy. The treatment is non-invasive and aims to reduce side effects.
This study tests whether adding electro-acupuncture (a gentle type of acupuncture with mild electrical pulses) to standard first-line immunotherapy and chemotherapy can help people with advanced non-small cell lung cancer. It aims to see if this combination improves quality of life and overall treatment outcomes.
This trial tests if adding acupuncture to standard immunotherapy and chemotherapy helps people with advanced lung cancer. It is for those who have not had treatment before and whose tumors have low PD-L1 levels.
Hear when a new Lung Cancer (NSCLC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.